94.82 0.7 (0.74%) | 07-26 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 111.53 | 1-year : | 130.26 |
Resists | First : | 95.48 | Second : | 111.53 |
Pivot price | 92.85 | |||
Supports | First : | 90.86 | Second : | 88 |
MAs | MA(5) : | 94.37 | MA(20) : | 91.93 |
MA(100) : | 86.75 | MA(250) : | 82.28 | |
MACD | MACD : | 1.5 | Signal : | 1.4 |
%K %D | K(14,3) : | 84.9 | D(3) : | 83.9 |
RSI | RSI(14): 70 | |||
52-week | High : | 95.48 | Low : | 71.97 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AFL ] has closed below upper band by 24.9%. Bollinger Bands are 57.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 95.29 - 95.87 | 95.87 - 96.42 |
Low: | 92.66 - 93.34 | 93.34 - 94 |
Close: | 93.78 - 94.78 | 94.78 - 95.74 |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Fri, 26 Jul 2024
Unveiling Aflac (AFL) Q2 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Thu, 25 Jul 2024
National Bank of Canada FI Increases Stock Holdings in Aflac Incorporated (NYSE:AFL) - MarketBeat
Wed, 24 Jul 2024
Aflac Incorporated (NYSE:AFL) Stake Cut by CANADA LIFE ASSURANCE Co - MarketBeat
Tue, 23 Jul 2024
AFLAC Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Mon, 22 Jul 2024
Aflac Incorporated (NYSE:AFL) Shares Acquired by Mitsubishi UFJ Trust & Banking Corp - Defense World
Mon, 22 Jul 2024
Aflac Incorporated (NYSE:AFL) Shares Bought by Blair William & Co. IL - Defense World
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NYSE
|
|
Sector:
Financial Services
|
|
Industry:
Insurance - Life
|
|
Shares Out | 568 (M) |
Shares Float | 563 (M) |
Held by Insiders | 9.9 (%) |
Held by Institutions | 60.4 (%) |
Shares Short | 14,900 (K) |
Shares Short P.Month | 15,010 (K) |
EPS | 9.09 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 41.27 |
Profit Margin | 27.6 % |
Operating Margin | 40.7 % |
Return on Assets (ttm) | 3 % |
Return on Equity (ttm) | 24.7 % |
Qtrly Rev. Growth | 13.3 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 34.03 |
EBITDA (p.s.) | 11.12 |
Qtrly Earnings Growth | 67.5 % |
Operating Cash Flow | 3,150 (M) |
Levered Free Cash Flow | 4,800 (M) |
PE Ratio | 10.43 |
PEG Ratio | 1.9 |
Price to Book value | 2.29 |
Price to Sales | 2.78 |
Price to Cash Flow | 17.1 |
Dividend | 0.5 |
Forward Dividend | 0 |
Dividend Yield | 0.5% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |